
Sign up to save your podcasts
Or


Charles Bernick, MD, MPH, discusses efficacy, patient selection and safety surveillance for anti-amyloid agents.
By Cleveland Clinic Neurological Institute4.9
3838 ratings
Charles Bernick, MD, MPH, discusses efficacy, patient selection and safety surveillance for anti-amyloid agents.

1,864 Listeners

494 Listeners

297 Listeners

255 Listeners

51 Listeners

289 Listeners

262 Listeners

3,338 Listeners

1,151 Listeners

87 Listeners

511 Listeners

364 Listeners

250 Listeners

179 Listeners

79 Listeners